FDA Slaps Natco With Form 483 Over Contamination Issues, Quality Lapses

The FDA smacked Natco Pharma for contamination problems and quality control lapses following an inspection of its Rangareddy, Telangana, India facility from Oct. 9 to 18.
Source: Drug Industry Daily